Literature DB >> 6606627

Endotoxin-induced in vitro release of interleukin-1 by cancer patients' monocytes: relation to stage of disease.

S Pollack, A Micali, D W Kinne, W E Enker, N Geller, H F Oettgen, M K Hoffmann.   

Abstract

The in vitro release of IL-1 by monocytes in response to endotoxin was subnormal in many patients with breast cancer, malignant melanoma or colorectal cancer but not in patients with benign tumors of the breast or colon. In each of these groups, IL-1 release was low in patients with early cancer, normal in patients with regional metastases, and low in patients with disseminated cancer.

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6606627     DOI： 10.1002/ijc.2910320613

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


  11 in total

1.  Effect of Nocardia rubra cell wall skeleton on augmentation of cytotoxicity function in human pleural macrophages.

Authors:  M Sakatani; T Ogura; T Masuno; S Kishimoto; Y Yamamura
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

2.  B-cell function in common variable immunodeficiency: suppression of in vitro anti-sheep erythrocytes antibody production by T cells and monocytes.

Authors:  S Pollack; Y Reisner; B Koziner; R A Good; M K Hoffman
Journal:  Immunology       Date:  1985-01       Impact factor: 7.397

3.  Defective production of leucocytic endogenous mediator (interleukin 1) by peripheral blood leucocytes of patients with systemic sclerosis, systemic lupus erythematosus, rheumatoid arthritis and mixed connective tissue disease.

Authors:  J T Whicher; A M Gilbert; C Westacott; C Hutton; P A Dieppe
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

4.  Viral reactivation as a cause of unexplained fever in patients with progressive metastatic breast cancer.

Authors:  S Rasoul-Rockenschaub; C C Zielinski; C Müller; E Tichatschek; T Popow-Kraupp; C Kunz
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

5.  Decreased interleukin generation in patients with cancer of the digestive system. A correlation between interleukin 1 and interleukin 2 production.

Authors:  Y Haga; K Sakamoto; Y Yokoyama; M Akagi
Journal:  Jpn J Surg       Date:  1988-09

6.  Interleukin-1 secretion by blood monocytes of septic premature infants.

Authors:  I Srugo; A Berger; Z Lapidot; S Pollak
Journal:  Infection       Date:  1991 May-Jun       Impact factor: 3.553

7.  Tumor cytotoxicity and interleukin 1 production of blood monocytes of lung cancer patients.

Authors:  S Sone; T Utsugi; P Tandon; H Yanagawa; A Okubo; T Ogura
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

Review 8.  The biological activities of interleukin-1.

Authors:  W E Fibbe; M R Schaafsma; J H Falkenburg; R Willemze
Journal:  Blut       Date:  1989-08

9.  Antitumour potential of pleural cavity macrophages in lung cancer patients without malignant effusion.

Authors:  S Kimura; S Sone; K Takahashi; T Uyama; T Ogura; Y Monden
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

10.  Interleukin-1 beta and interleukin-6 release by peripheral blood monocytes in head and neck cancer.

Authors:  O Gallo; A M Gori; M Attanasio; F Martini; B Giusti; M Boddi; E Gallina; O Fini; R Abbate
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.